Baird Medical Investment Holdings LtdBDMDEarnings & Financial Report
Nasdaq
NextMar 31, 2026
BDMD Q2 2025 Key Financial Metrics
Revenue
$13.1M
Gross Profit
$11.5M
Operating Profit
$5.1M
Net Profit
$4.4M
Gross Margin
87.5%
Operating Margin
38.7%
Net Margin
33.3%
YoY Growth
N/A
Financial Flow
Baird Medical Investment Holdings Ltd Q2 2025 Financial Summary
Baird Medical Investment Holdings Ltd reported revenue of $13.1M for Q2 2025, with a net profit of $4.4M (33.3% margin). Cost of goods sold was $1.6M, operating expenses totaled $6.4M.
Key Financial Metrics
| Total Revenue | $13.1M |
|---|---|
| Net Profit | $4.4M |
| Gross Margin | 87.5% |
| Operating Margin | 38.7% |
| Report Period | Q2 2025 |
Income Statement
| Q2 2025 | |
|---|---|
| Revenue | $13.1M |
| YoY Growth | N/A |
Balance Sheet
| Q2 2025 | |
|---|---|
| Assets | $77.0M |
| Liabilities | $41.4M |
| Equity | $35.6M |
Cash Flow
| Q2 2025 | |
|---|---|
| Operating CF | $-4.0M |